Furthermore, high hSSB2 expression was found to be associated with worse breast cancer prognosis, while downregulation of hSSB2 expression in triple‐negative breast cancer cells inhibited cell proliferation and migration and promoted apoptosis (Wu et al., 2021). Here, NABP1 is linked to breast cancer.